- Report
- October 2025
- 191 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- October 2025
- 187 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- October 2025
- 180 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- October 2025
- 186 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 187 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 182 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 190 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 187 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 182 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 197 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 194 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 188 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 188 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 197 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 194 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 181 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 188 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 186 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 193 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP
- Report
- August 2025
- 193 Pages
Global
From €3180EUR$3,545USD£2,797GBP
€3534EUR$3,939USD£3,108GBP

High Throughput Sequencing (HTS) is a biotechnology technique used to rapidly sequence large amounts of DNA or RNA. It is used to identify genetic variations, detect mutations, and analyze gene expression. HTS is used in a variety of applications, including drug discovery, diagnostics, and personalized medicine. It is also used in research to study the genetic basis of diseases, to identify biomarkers, and to understand the evolution of species.
HTS has revolutionized the biotechnology industry, allowing researchers to quickly and accurately sequence large amounts of genetic material. This has enabled the development of new treatments and diagnostics, as well as the identification of new biomarkers.
Companies in the HTS market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10X Genomics. Show Less Read more